首页|A novel shark VNAR antibody-based immunotoxin targeting TROP-2 for cancer therapy

A novel shark VNAR antibody-based immunotoxin targeting TROP-2 for cancer therapy

扫码查看
原文链接
  • 万方数据
  • 维普
TROP-2,a tumor-associated antigen,has been implicated in the progression of various epithelial tumors.Due to its favorable expression profile,TROP-2 has emerged as a promising target for antibody-drug conjugates(ADCs)based anti-tumor therapies.Although ADCs have shown efficacy in cancer treatment,their application in solid tumors is hindered by their high molecular weight,poor tumor penetration,and release of cytotoxic molecules.Therefore,a recombinant immunotoxin was devel-oped based on a shark-derived variable domain of immunoglobulin new antigen receptor(VNAR)anti-body.VNARs are only one-tenth the size of IgG antibodies and possess remarkable tissue penetration capabilities and high stability.In this study,a shark VNAR phage display library was created,leading to the identification of shark VNAR-5G8 that targets TROP-2.VNAR-5G8 exhibited a high affinity and cellular internalization ability towards cells expressing high levels of TROP-2.Epitope analysis revealed that VNAR-5G8 recognizes a hidden epitope consisting of CRD and TY-1 on TROP-2.Subsequently,VNAR-5G8 was fused with a truncated form of Pseudomonas exotoxin(PE38)to create the recombinant immunotoxin(5G8-PE38),which exhibited significant anti-tumor activity in vitro and in vivo.Overall,this study highlights the promise of 5G8-PE38 as a valuable candidate for cancer therapy.

Shark VNARImmunotoxinsTROP-2Epitope identificationAnti-tumorPseudomonas exotoxin ANanobodyBreast cancer

Xiaozhi Xi、Yanqing Wang、Guiqi An、Shitao Feng、Qiumei Zhu、Zhongqiu Wu、Jin Chen、Zhicheng Zuo、Qiang Wang、Ming-Wei Wang、Yuchao Gu

展开 >

College of Marine Science and Biological Engineering,Qingdao University of Science and Technology,Qingdao 266042,China

Laboratory for Marine Drugs and Bioproducts of Qingdao Marine Science and Technology Center School of Medicine and Pharmacy,Ocean University of China,Qingdao 266003,China

Oncology Department,Shandong Second Provincial General Hospital,Jinan 250022,China

College of Chemistry and Chemical Engineering,Shanghai University of Engineering Science,Shanghai 201620,China

Research Center for Deepsea Bioresources(Sanya),Hainan 572025,China

展开 >

2024

10.1016/j.apsb.2024.08.023

药学学报(英文版)

药学学报(英文版)

CSTPCD
ISSN：
年,卷(期)：2024.14(11)